{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T18:04:27Z","timestamp":1649009067497},"reference-count":0,"publisher":"BMJ","issue":"nov07 15","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"published-print":{"date-parts":[[2014,11,9]]},"DOI":"10.1136\/bmj.g6715","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T06:54:03Z","timestamp":1415602443000},"page":"g6715-g6715","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Heroin substitute treatment should not be time limited, says report commissioned by government"],"prefix":"10.1136","volume":"349","author":[{"given":"I.","family":"Torjesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,11,9]]},"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.g6715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:55:16Z","timestamp":1601060116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.g6715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,9]]},"references-count":0,"journal-issue":{"issue":"nov07 15","published-online":{"date-parts":[[2014,11,9]]},"published-print":{"date-parts":[[2014,11,7]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.g6715","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,9]]}}}